Assessment of inhibitory effect of letrozole on hepatic fibrosis
Not Applicable
Recruiting
- Conditions
- The patients who were treated with letrozole and conducted blood tests of hepatic function
- Registration Number
- JPRN-UMIN000041649
- Lead Sponsor
- Osaka International Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Age, sex, platelet count, AST, ALT, BMI level (weight, height), blood glucose level, HbA1c, blood albumin
- Secondary Outcome Measures
Name Time Method